This article is more than 5 years old. Information may no longer be current.

VIDEO: Expert Forecasts 2016 Hot Topics in IBD

Issue: February 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO — Miguel Regueiro, MD, AGAF, FACG, professor of medicine at University of Pittsburgh, discusses his AIBD presentation on what will be the hot clinical topics in IBD in 2016.

“The talk I gave on the hot topics really revolved around four subject areas,” Regueiro said. “One are biosimilars; [another] is when and if we can stop medications; the third is positioning our current biologic therapies in IBD; and then, finally, these concepts of new models of care in 2016 and beyond, and I touched a little bit upon our patient-centered medical home.”

Disclosures: Regueiro reports he is a consultant for AbbVie, Janssen, Shire, Takeda and UCB.